Stocks and Investing Stocks and Investing
Fri, January 27, 2023
[ 12:00 AM ] - United States, WOPRAI
Bill Katz Maintained (TROW) at Sell with Decreased Target to $65 on, Jan 27th, 2023
[ 12:00 AM ] - United States, WOPRAI
James Fotheringham Maintained (TROW) at Hold with Decreased Target to $90 on, Jan 27th, 2023
[ 12:00 AM ] - United States, WOPRAI
Kenneth Worthington Maintained (TROW) at Sell with Decreased Target to $95 on, Jan 27th, 2023
[ 12:00 AM ] - United States, WOPRAI
Brian Bedell Maintained (TROW) at Hold with Decreased Target to $113 on, Jan 27th, 2023
[ 12:00 AM ] - United States, WOPRAI
Nick McKay Initiated (TTWO) at Buy and Held Target at $140 on, Jan 27th, 2023
[ 12:00 AM ] - United States, WOPRAI
Clay Griffin Upgraded (TTWO) to Buy and Held Target at $140 on, Jan 27th, 2023
[ 12:00 AM ] - United States, WOPRAI
J. Bruce Chan Maintained (UPS) at Strong Buy and Held Target at $202 on, Jan 27th, 2023
[ 12:00 AM ] - United States, WOPRAI
David Long Maintained (UMBF) at Buy with Increased Target to $104 on, Jan 27th, 2023
[ 12:00 AM ] - United States, WOPRAI
Michael Ulz Maintained (ALVR) at Buy with Decreased Target to $20 on, Jan 27th, 2023
[ 12:00 AM ] - United States, WOPRAI
Michael Ulz Maintained (ALLK) at Hold with Increased Target to $8 on, Jan 27th, 2023
[ 12:00 AM ] - United States, WOPRAI
Michael Rose Maintained (TFIN) at Buy with Decreased Target to $67 on, Jan 27th, 2023
[ 12:00 AM ] - United States, WOPRAI
Matt Olney Maintained (TFIN) at Hold with Decreased Target to $58 on, Jan 27th, 2023
[ 12:00 AM ] - United States, WOPRAI
Scott Graham Downgraded (TER) to Hold and Held Target at $102 on, Jan 27th, 2023
[ 12:00 AM ] - United States, WOPRAI
Joseph Moore Maintained (TER) at Hold with Increased Target to $101 on, Jan 27th, 2023
[ 12:00 AM ] - United States, WOPRAI
Gus Richard Maintained (TER) at Hold with Increased Target to $97 on, Jan 27th, 2023
[ 12:00 AM ] - United States, WOPRAI
Vedvati Shrotre Maintained (TER) at Strong Buy and Held Target at $120 on, Jan 27th, 2023
[ 12:00 AM ] - United States, WOPRAI
Timothy Arcuri Maintained (TER) at Strong Buy with Increased Target to $125 on, Jan 27th, 2023
[ 12:00 AM ] - United States, WOPRAI
Christian Schwab Maintained (TER) at Strong Buy with Increased Target to $131 on, Jan 27th, 2023
[ 12:00 AM ] - United States, WOPRAI
Vivek Arya Maintained (TER) at Hold with Increased Target to $115 on, Jan 27th, 2023
[ 12:00 AM ] - United States, WOPRAI
Howard Ma Initiated (TDC) at Hold on, Jan 27th, 2023
[ 12:00 AM ] - United States, WOPRAI
James Faucette Maintained (TASK) at Hold with Increased Target to $20 on, Jan 27th, 2023
[ 12:00 AM ] - United States, WOPRAI
Scott Group Downgraded (ALK) to Hold on, Jan 27th, 2023
[ 12:00 AM ] - United States, WOPRAI
Brandon Oglenski Maintained (ALK) at Hold with Increased Target to $54 on, Jan 27th, 2023
[ 12:00 AM ] - United States, WOPRAI
Jamie Baker Maintained (ALK) at Buy with Increased Target to $91 on, Jan 27th, 2023
[ 12:00 AM ] - United States, WOPRAI
Paul Newsome Maintained (AJG) at Hold with Increased Target to $215 on, Jan 27th, 2023
[ 12:00 AM ] - United States, WOPRAI
Elyse Greenspan Maintained (AJG) at Buy with Increased Target to $233 on, Jan 27th, 2023
[ 12:00 AM ] - United States, WOPRAI
Ken Newman Maintained (AIT) at Buy with Increased Target to $162 on, Jan 27th, 2023
[ 12:00 AM ] - United States, WOPRAI
David Manthey Maintained (AIT) at Hold with Increased Target to $160 on, Jan 27th, 2023
[ 12:00 AM ] - United States, WOPRAI
Chris Dankert Maintained (AIT) at Strong Buy with Increased Target to $170 on, Jan 27th, 2023
[ 12:00 AM ] - United States, WOPRAI
Michael Ulz Upgraded (AKRO) to Buy and Held Target at $65 on, Jan 27th, 2023

Michael Ulz Upgraded (AKRO) to Buy and Held Target at $65 on, Jan 27th, 2023


Published on 2024-10-28 01:10:06 - WOPRAI, Michael Ulz
  Print publication without navigation


Michael Ulz of Morgan Stanley, Upgraded "Akero Therapeutics, Inc." (AKRO) to Buy and Held Target at $65 on, Jan 27th, 2023.

Michael has made no other calls on AKRO in the last 4 months.



There are 2 other peers that have a rating on AKRO. Out of the 2 peers that are also analyzing AKRO, 1 agrees with Michael's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $40 on, Monday, November 7th, 2022


This is the rating of the analyst that currently disagrees with Michael

  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $64 on, Monday, November 7th, 2022

Contributing Sources